Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

FDA Approves 1st Drug For Treating Aggressive Multiple Sclerosis

drugGenentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved OCREVUS™ (ocrelizumab) as the first and only medicine for both relapsing and primary progressive forms of multiple sclerosis. The majority of people with MS have a relapsing form or primary progressive […]


This post first appeared on Biotechin.asia – Your Daily Biotech And Healthca, please read the originial post: here

Share the post

FDA Approves 1st Drug For Treating Aggressive Multiple Sclerosis

×

Subscribe to Biotechin.asia – Your Daily Biotech And Healthca

Get updates delivered right to your inbox!

Thank you for your subscription

×